Mora Telematika Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mora Telematika Indonesia Tbk. trades at Rp5,175 (market cap 254.4T, 166K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mora Telematika Indonesia Tbk. is far larger — about 2436.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MORA | SCPI | |
|---|---|---|
Market Cap | 254.4T | 104.4B |
Volume | 166K | — |
Lot | 1.66K | — |
Turnover | 863.82M | — |
Average Price | 5,203.75 | — |
Value | 863.82M | — |
Indicative Equilibrium Price | 5,175 | — |
Indicative Equilibrium Volume | 45 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Mora Telematika Indonesia Tbk (the Company) was established based on the Notarial Deed No. 30 dated August 8, 2000 of Daniel Parganda Marpaung, S.H., a public notary in Jakarta. The Company started its commercial operations in 2001. PT Candrakarya Multikreasi is the parent company. Ir. Galumbang Menak and Farida Bau are the ultimate shareholders of the Company and its subsidiaries (herein after referred to as the Group). The Group is incorporated in Indonesia and conduct its operations in Indonesia and Singapore.
Read more on MORA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →